iZafe Group

iZafe Group R&D per Employee

The R&D Spending per Employee of iZafe Group (IZAFE B.ST) as of Nov 19, 2026 is 257,636.36 SEK. In the previous year, R&D Spending per Employee was 284,272.73 SEK — a change of -9.37% (lower).

R&D per Employee

257,636.36SEK

YoY

-9.37%

Last updated:

R&D Spending per Employee of iZafe Group is 2024 257,636.36 SEK. R&D Spending per Employee of iZafe Group was 2023 284,272.73 SEK. It decreases by -9.37% lower compared to the previous year.

The iZafe Group R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2019
356,636.36 SEK
Jan 1, 2020
356,727.27 SEK
Jan 1, 2021
356,727.27 SEK
Jan 1, 2022
263,636.36 SEK
Jan 1, 2023
284,272.73 SEK
Jan 1, 2024
257,636.36 SEK
The iZafe Group R&D per Employee history
YEARR&D per EmployeeYoY
257,636.36SEK-9.37%
284,272.73SEK+7.83%
263,636.36SEK-26.10%
356,727.27SEK0.00%
356,727.27SEK+0.03%
356,636.36SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

iZafe Group Stock analysis

What does iZafe Group do? iZafe Group AB develops medical and digital security solutions, including Dosell, a patented drug dispenser for home medication with remote monitoring, and MediKoll, an app providing medication side effect and allergy information. The company serves pharmaceutical companies, hospitals, care homes, and pharmacies in the global market. Its products target patients and healthcare providers seeking secure, remote medication management and personalized health information. Dosell is under development as a home medication solution, while MediKoll offers real-time data on medication reactions. The firm's revenue comes from selling these digital tools to healthcare institutions and pharmaceutical partners, focusing on improving patient safety and reducing medication errors through technology. iZafe Group AB's business model relies on the global healthcare sector's demand for innovative digital tools. The company's offerings are tailored for pharmaceutical firms, hospitals, care homes, and pharmacies, leveraging remote monitoring capabilities to address medication management challenges in home and clinical settings. iZafe Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about iZafe Group stock

R&D Spending per Employee of iZafe Group is 257,636.36 SEK in 2024.

R&D Spending per Employee of iZafe Group changed from 284,272.73 SEK to 257,636.36 SEK, representing a -9.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee iZafe Group since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's iZafe Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — iZafe Group

All Key Metrics — iZafe Group